Novel motif:130: Difference between revisions
From FANTOM5_SSTAR
(Created page with "{{Novel_motif
|name=motif130_TTTCAAACNCCC
|novel_motifs_human_sample_pval=11376-118A8_11051;0.371796,11327-117E4_11969;0.693837,11473-119C6_11054;0.391873,11474-119C7_12067;...") |
No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 15:14, 9 September 2013
name: | motif130_TTTCAAACNCCC |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0042074 | cell migration involved in gastrulation | 3.459862e-13 |
GO:0006020 | inositol metabolic process | 1.026231e-12 |
GO:0034377 | plasma lipoprotein particle assembly | 3.705502e-11 |
GO:0008078 | mesodermal cell migration | 3.991508e-11 |
GO:0034379 | very-low-density lipoprotein particle assembly | 3.994037e-10 |
GO:0010269 | response to selenium ion | 1.253411e-9 |
GO:0000185 | activation of MAPKKK activity | 1.403009e-9 |
GO:0007509 | mesoderm migration involved in gastrulation | 8.210488e-9 |
GO:0051901 | positive regulation of mitochondrial depolarization | 1.561253e-8 |
GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 2.936635e-8 |
GO:0002889 | regulation of immunoglobulin mediated immune response | 3.948306e-8 |
GO:0032964 | collagen biosynthetic process | 4.961207e-8 |
GO:0001957 | intramembranous ossification | 7.044383e-8 |
GO:0002712 | regulation of B cell mediated immunity | 7.541009e-8 |
GO:0031536 | positive regulation of exit from mitosis | 7.637238e-8 |
GO:0090101 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.541378e-7 |
GO:0046543 | development of secondary female sexual characteristics | 1.774175e-7 |
GO:0019751 | polyol metabolic process | 1.985985e-7 |
GO:0000075 | cell cycle checkpoint | 2.125569e-7 |
GO:0006689 | ganglioside catabolic process | 3.270192e-7 |
GO:0003307 | regulation of Wnt receptor signaling pathway involved in heart development | 4.478891e-7 |
GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway | 6.450902e-7 |
GO:0090100 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 6.598272e-7 |
GO:0010954 | positive regulation of protein processing | 6.898868e-7 |
GO:0035814 | negative regulation of renal sodium excretion | 6.952313e-7 |
GO:0071156 | regulation of cell cycle arrest | 6.993046e-7 |
GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation | 7.621984e-7 |
GO:0045136 | development of secondary sexual characteristics | 9.100880e-7 |
GO:0071316 | cellular response to nicotine | 1.095117e-6 |
GO:0048853 | forebrain morphogenesis | 1.260072e-6 |
GO:0060393 | regulation of pathway-restricted SMAD protein phosphorylation | 1.303206e-6 |
GO:0070245 | positive regulation of thymocyte apoptosis | 1.430519e-6 |
GO:0070230 | positive regulation of lymphocyte apoptosis | 1.442893e-6 |
GO:0070417 | cellular response to cold | 1.740725e-6 |
GO:0070243 | regulation of thymocyte apoptosis | 1.981187e-6 |
GO:0060167 | regulation of adenosine receptor signaling pathway | 2.124738e-6 |
GO:0033555 | multicellular organismal response to stress | 2.288917e-6 |
GO:0042542 | response to hydrogen peroxide | 3.021802e-6 |
GO:0030514 | negative regulation of BMP signaling pathway | 3.403390e-6 |
GO:0070234 | positive regulation of T cell apoptosis | 3.573805e-6 |
GO:0022027 | interkinetic nuclear migration | 3.762978e-6 |
GO:0055093 | response to hyperoxia | 5.092982e-6 |
GO:0031133 | regulation of axon diameter | 5.432785e-6 |
GO:0007093 | mitotic cell cycle checkpoint | 6.711649e-6 |
GO:0043585 | nose morphogenesis | 7.117160e-6 |
GO:0033590 | response to cobalamin | 7.449616e-6 |
GO:0006117 | acetaldehyde metabolic process | 7.449616e-6 |
GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway | 7.504429e-6 |
GO:0043320 | natural killer cell degranulation | 7.697330e-6 |
GO:0003308 | negative regulation of Wnt receptor signaling pathway involved in heart development | 8.161387e-6 |
GO:0007051 | spindle organization | 8.183523e-6 |
GO:0070232 | regulation of T cell apoptosis | 8.421221e-6 |
GO:0060343 | trabecula formation | 8.658899e-6 |
GO:0006097 | glyoxylate cycle | 8.982419e-6 |
GO:0051293 | establishment of spindle localization | 9.051827e-6 |
GO:0035419 | activation of MAPK activity involved in innate immune response | 9.138965e-6 |
GO:0034389 | lipid particle organization | 9.160432e-6 |
GO:0046491 | L-methylmalonyl-CoA metabolic process | 9.755547e-6 |
GO:0016554 | cytidine to uridine editing | 9.755547e-6 |
GO:0045191 | regulation of isotype switching | 1.018181e-5 |
GO:0035556 | intracellular signal transduction | 1.164228e-5 |
GO:0042159 | lipoprotein catabolic process | 1.176892e-5 |
GO:0000077 | DNA damage checkpoint | 1.182433e-5 |
GO:0002739 | regulation of cytokine secretion involved in immune response | 1.208909e-5 |
GO:0031627 | telomeric loop formation | 1.281151e-5 |
GO:0035121 | tail morphogenesis | 1.383272e-5 |
GO:0050768 | negative regulation of neurogenesis | 1.540835e-5 |
GO:0042360 | vitamin E metabolic process | 1.574042e-5 |
GO:0030844 | positive regulation of intermediate filament depolymerization | 1.574042e-5 |
GO:0042596 | fear response | 1.583964e-5 |
GO:0032926 | negative regulation of activin receptor signaling pathway | 1.586138e-5 |
GO:0061383 | trabecula morphogenesis | 1.592792e-5 |
GO:0030510 | regulation of BMP signaling pathway | 1.598767e-5 |
GO:0009264 | deoxyribonucleotide catabolic process | 1.600725e-5 |
GO:0030953 | astral microtubule organization | 1.655955e-5 |
GO:0009155 | purine deoxyribonucleotide catabolic process | 1.692276e-5 |
GO:0002740 | negative regulation of cytokine secretion involved in immune response | 1.740071e-5 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt receptor signaling pathway | 1.753528e-5 |
GO:0019882 | antigen processing and presentation | 1.870326e-5 |
GO:0046853 | inositol or phosphatidylinositol phosphorylation | 1.927763e-5 |
GO:0060389 | pathway-restricted SMAD protein phosphorylation | 1.983906e-5 |
GO:0060346 | bone trabecula formation | 2.124672e-5 |
GO:0007626 | locomotory behavior | 2.351911e-5 |
GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation | 2.352729e-5 |
GO:0006779 | porphyrin-containing compound biosynthetic process | 3.172620e-5 |
GO:0000302 | response to reactive oxygen species | 3.208790e-5 |
GO:0045065 | cytotoxic T cell differentiation | 3.490473e-5 |
GO:0071206 | establishment of protein localization to juxtaparanode region of axon | 3.552397e-5 |
GO:0060168 | positive regulation of adenosine receptor signaling pathway | 3.552397e-5 |
GO:0030149 | sphingolipid catabolic process | 3.562944e-5 |
GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 3.577875e-5 |
GO:0021509 | roof plate formation | 4.045209e-5 |
GO:0032536 | regulation of cell projection size | 4.079373e-5 |
GO:0071300 | cellular response to retinoic acid | 4.115629e-5 |
GO:0007605 | sensory perception of sound | 4.260634e-5 |
GO:0060744 | mammary gland branching involved in thelarche | 4.438851e-5 |
GO:0045416 | positive regulation of interleukin-8 biosynthetic process | 4.644057e-5 |
GO:0006285 | base-excision repair, AP site formation | 4.727291e-5 |
GO:0046479 | glycosphingolipid catabolic process | 4.764168e-5 |
GO:0042267 | natural killer cell mediated cytotoxicity | 5.080972e-5 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 5.336818e-5 |
GO:0000722 | telomere maintenance via recombination | 5.447727e-5 |
GO:0006312 | mitotic recombination | 5.510234e-5 |
GO:0031860 | telomeric 3' overhang formation | 5.536820e-5 |
GO:0048592 | eye morphogenesis | 5.558396e-5 |
GO:0032924 | activin receptor signaling pathway | 5.619330e-5 |
GO:0046501 | protoporphyrinogen IX metabolic process | 5.661484e-5 |
GO:0045682 | regulation of epidermis development | 5.768570e-5 |
GO:0045007 | depurination | 5.769286e-5 |
GO:0010994 | free ubiquitin chain polymerization | 5.769286e-5 |
GO:0071312 | cellular response to alkaloid | 5.875769e-5 |
GO:0034505 | tooth mineralization | 5.938971e-5 |
GO:0006499 | N-terminal protein myristoylation | 5.981674e-5 |
GO:0031570 | DNA integrity checkpoint | 6.110909e-5 |
GO:0031064 | negative regulation of histone deacetylation | 6.119571e-5 |
GO:0044319 | wound healing, spreading of cells | 6.122791e-5 |
GO:0045994 | positive regulation of translational initiation by iron | 6.318061e-5 |
GO:0002037 | negative regulation of L-glutamate transport | 6.318061e-5 |
GO:0042137 | sequestering of neurotransmitter | 6.493966e-5 |
GO:0035023 | regulation of Rho protein signal transduction | 6.770801e-5 |
GO:0040001 | establishment of mitotic spindle localization | 6.782551e-5 |
GO:0003254 | regulation of membrane depolarization | 7.137611e-5 |
GO:0038007 | netrin-activated signaling pathway | 7.147945e-5 |
GO:0007266 | Rho protein signal transduction | 7.181259e-5 |
GO:0051260 | protein homooligomerization | 7.249038e-5 |
GO:0002863 | positive regulation of inflammatory response to antigenic stimulus | 7.624930e-5 |
GO:0090130 | tissue migration | 8.271145e-5 |
GO:0046931 | pore complex assembly | 8.377495e-5 |
GO:0009062 | fatty acid catabolic process | 8.536066e-5 |
GO:0007265 | Ras protein signal transduction | 8.767794e-5 |
GO:0051532 | regulation of NFAT protein import into nucleus | 8.813409e-5 |
GO:0051896 | regulation of protein kinase B signaling cascade | 8.937593e-5 |
GO:0019230 | proprioception | 9.189377e-5 |
GO:0009151 | purine deoxyribonucleotide metabolic process | 9.881740e-5 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 1.001730e-4 |
GO:0060621 | negative regulation of cholesterol import | 1.004798e-4 |
GO:0034384 | high-density lipoprotein particle clearance | 1.013728e-4 |
GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 1.018117e-4 |
GO:0060157 | urinary bladder development | 1.027866e-4 |
GO:0002637 | regulation of immunoglobulin production | 1.034489e-4 |
GO:0006635 | fatty acid beta-oxidation | 1.065727e-4 |
GO:0002088 | lens development in camera-type eye | 1.078274e-4 |
GO:0000132 | establishment of mitotic spindle orientation | 1.081911e-4 |
GO:0001909 | leukocyte mediated cytotoxicity | 1.112993e-4 |
GO:0060689 | cell differentiation involved in salivary gland development | 1.123442e-4 |
GO:0001306 | age-dependent response to oxidative stress | 1.129610e-4 |
GO:0033025 | regulation of mast cell apoptosis | 1.168987e-4 |
GO:0022616 | DNA strand elongation | 1.182541e-4 |
GO:0051798 | positive regulation of hair follicle development | 1.221972e-4 |
GO:0000060 | protein import into nucleus, translocation | 1.279044e-4 |
GO:0032319 | regulation of Rho GTPase activity | 1.285876e-4 |
GO:0000086 | G2/M transition of mitotic cell cycle | 1.305840e-4 |
GO:0032862 | activation of Rho GTPase activity | 1.327488e-4 |
GO:0051298 | centrosome duplication | 1.328807e-4 |
GO:0043243 | positive regulation of protein complex disassembly | 1.348523e-4 |
GO:0006447 | regulation of translational initiation by iron | 1.427113e-4 |
GO:0009967 | positive regulation of signal transduction | 1.446405e-4 |
GO:0050957 | equilibrioception | 1.531116e-4 |
GO:0032148 | activation of protein kinase B activity | 1.549023e-4 |
GO:2000309 | positive regulation of tumor necrosis factor (ligand) superfamily member 11 production | 1.605790e-4 |
GO:0046466 | membrane lipid catabolic process | 1.649809e-4 |
GO:0021877 | forebrain neuron fate commitment | 1.660178e-4 |
GO:0002861 | regulation of inflammatory response to antigenic stimulus | 1.672197e-4 |
GO:0051488 | activation of anaphase-promoting complex activity | 1.674325e-4 |
GO:0034380 | high-density lipoprotein particle assembly | 1.702773e-4 |
GO:0019048 | virus-host interaction | 1.703893e-4 |
GO:0021893 | cerebral cortex GABAergic interneuron fate commitment | 1.744055e-4 |
GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment | 1.744055e-4 |
GO:0016973 | poly(A)+ mRNA export from nucleus | 1.748874e-4 |
GO:0051602 | response to electrical stimulus | 1.774143e-4 |
GO:0071299 | cellular response to vitamin A | 1.777338e-4 |
GO:0042772 | DNA damage response, signal transduction resulting in transcription | 1.817695e-4 |
GO:0042994 | cytoplasmic sequestering of transcription factor | 1.920639e-4 |
GO:0070159 | mitochondrial threonyl-tRNA aminoacylation | 1.968711e-4 |
GO:0001845 | phagolysosome assembly | 1.984887e-4 |
GO:0010721 | negative regulation of cell development | 1.998285e-4 |
GO:0003198 | epithelial to mesenchymal transition involved in endocardial cushion formation | 2.040187e-4 |
GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 2.104603e-4 |
GO:0010564 | regulation of cell cycle process | 2.156503e-4 |
GO:0060686 | negative regulation of prostatic bud formation | 2.221145e-4 |
GO:0048048 | embryonic eye morphogenesis | 2.290954e-4 |
GO:0060973 | cell migration involved in heart development | 2.300566e-4 |
GO:0007221 | positive regulation of transcription of Notch receptor target | 2.315967e-4 |
GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase | 2.320357e-4 |
GO:0003032 | detection of oxygen | 2.352051e-4 |
GO:2000836 | positive regulation of androgen secretion | 2.426754e-4 |
GO:0006768 | biotin metabolic process | 2.426754e-4 |
GO:2000500 | positive regulation of induction of apoptosis in response to chemical stimulus | 2.426754e-4 |
GO:0032526 | response to retinoic acid | 2.450908e-4 |
GO:0005980 | glycogen catabolic process | 2.471656e-4 |
GO:0010189 | vitamin E biosynthetic process | 2.474249e-4 |
GO:0033013 | tetrapyrrole metabolic process | 2.494567e-4 |
GO:0071779 | G1/S transition checkpoint | 2.505278e-4 |
GO:2000678 | negative regulation of transcription regulatory region DNA binding | 2.515372e-4 |
GO:0001662 | behavioral fear response | 2.549454e-4 |
GO:0019101 | female somatic sex determination | 2.615980e-4 |
GO:0042703 | menstruation | 2.615980e-4 |
GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 2.636480e-4 |
GO:0097151 | positive regulation of inhibitory postsynaptic membrane potential | 2.677162e-4 |
GO:0048320 | axial mesoderm formation | 2.735408e-4 |
GO:0060620 | regulation of cholesterol import | 2.735408e-4 |
GO:0015824 | proline transport | 2.754645e-4 |
GO:0002431 | Fc receptor mediated stimulatory signaling pathway | 2.754672e-4 |
GO:0001805 | positive regulation of type III hypersensitivity | 2.754672e-4 |
GO:0031848 | protection from non-homologous end joining at telomere | 2.765684e-4 |
GO:0072331 | signal transduction by p53 class mediator | 2.779944e-4 |
GO:0006471 | protein ADP-ribosylation | 2.789399e-4 |
GO:0060816 | random inactivation of X chromosome | 2.836229e-4 |
GO:0030330 | DNA damage response, signal transduction by p53 class mediator | 2.860590e-4 |
GO:0009258 | 10-formyltetrahydrofolate catabolic process | 2.866199e-4 |
GO:0051181 | cofactor transport | 2.888697e-4 |
GO:0006333 | chromatin assembly or disassembly | 3.037253e-4 |
GO:0010874 | regulation of cholesterol efflux | 3.113046e-4 |
GO:0007468 | regulation of rhodopsin gene expression | 3.153197e-4 |
GO:0072355 | histone H3-T3 phosphorylation | 3.227257e-4 |
GO:0008049 | male courtship behavior | 3.227257e-4 |
GO:0001963 | synaptic transmission, dopaminergic | 3.351715e-4 |
GO:0072329 | monocarboxylic acid catabolic process | 3.415854e-4 |
GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway | 3.536286e-4 |
GO:0051955 | regulation of amino acid transport | 3.610339e-4 |
GO:0010799 | regulation of peptidyl-threonine phosphorylation | 3.611372e-4 |
GO:0045112 | integrin biosynthetic process | 3.624968e-4 |
GO:0031571 | mitotic cell cycle G1/S transition DNA damage checkpoint | 3.629248e-4 |
GO:0043589 | skin morphogenesis | 3.695598e-4 |
GO:0035966 | response to topologically incorrect protein | 3.703281e-4 |
GO:0090082 | positive regulation of heart induction by negative regulation of canonical Wnt receptor signaling pathway | 3.723830e-4 |
GO:0006435 | threonyl-tRNA aminoacylation | 3.723830e-4 |
GO:0048593 | camera-type eye morphogenesis | 3.723899e-4 |
GO:0090381 | regulation of heart induction | 3.759215e-4 |
GO:0030825 | positive regulation of cGMP metabolic process | 3.790349e-4 |
GO:0045629 | negative regulation of T-helper 2 cell differentiation | 3.879881e-4 |
GO:0000212 | meiotic spindle organization | 3.942859e-4 |
GO:0032730 | positive regulation of interleukin-1 alpha production | 3.948805e-4 |
GO:0071827 | plasma lipoprotein particle organization | 3.983651e-4 |
GO:0002089 | lens morphogenesis in camera-type eye | 3.990391e-4 |
GO:0051964 | negative regulation of synapse assembly | 4.242158e-4 |
GO:0002432 | granuloma formation | 4.276643e-4 |
GO:0002209 | behavioral defense response | 4.293439e-4 |
GO:0045684 | positive regulation of epidermis development | 4.306241e-4 |
GO:2000045 | regulation of G1/S transition of mitotic cell cycle | 4.515855e-4 |
GO:0006778 | porphyrin-containing compound metabolic process | 4.517657e-4 |
GO:0032321 | positive regulation of Rho GTPase activity | 4.520780e-4 |
GO:0006102 | isocitrate metabolic process | 4.575560e-4 |
GO:0048265 | response to pain | 4.584246e-4 |
GO:0072676 | lymphocyte migration | 4.614401e-4 |
GO:0072500 | negative regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor | 4.639331e-4 |
GO:0032963 | collagen metabolic process | 4.721922e-4 |
GO:0010826 | negative regulation of centrosome duplication | 4.889648e-4 |
GO:0007091 | mitotic metaphase/anaphase transition | 4.905295e-4 |
GO:0007243 | intracellular protein kinase cascade | 5.006351e-4 |
GO:0051900 | regulation of mitochondrial depolarization | 5.124336e-4 |
GO:0019395 | fatty acid oxidation | 5.141351e-4 |
GO:0060056 | mammary gland involution | 5.294053e-4 |
GO:0051701 | interaction with host | 5.442138e-4 |
GO:0006642 | triglyceride mobilization | 5.459695e-4 |
GO:0035313 | wound healing, spreading of epidermal cells | 5.482796e-4 |
GO:0010875 | positive regulation of cholesterol efflux | 5.561787e-4 |
GO:0031575 | mitotic cell cycle G1/S transition checkpoint | 5.574765e-4 |
GO:0000272 | polysaccharide catabolic process | 5.634521e-4 |
GO:0030859 | polarized epithelial cell differentiation | 5.742219e-4 |
GO:0050954 | sensory perception of mechanical stimulus | 5.797638e-4 |
GO:0044242 | cellular lipid catabolic process | 5.798955e-4 |
GO:0042992 | negative regulation of transcription factor import into nucleus | 5.905464e-4 |
GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway | 5.982928e-4 |
GO:0051259 | protein oligomerization | 6.275441e-4 |
GO:0010800 | positive regulation of peptidyl-threonine phosphorylation | 6.361815e-4 |
GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis | 6.373013e-4 |
GO:0014028 | notochord formation | 6.431738e-4 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 6.516216e-4 |
GO:0007164 | establishment of tissue polarity | 6.728535e-4 |
GO:0071346 | cellular response to interferon-gamma | 6.898057e-4 |
GO:0050717 | positive regulation of interleukin-1 alpha secretion | 7.002067e-4 |
GO:0035470 | positive regulation of vascular wound healing | 7.002067e-4 |
GO:0007223 | Wnt receptor signaling pathway, calcium modulating pathway | 7.012723e-4 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 7.164947e-4 |
GO:0051461 | positive regulation of corticotropin secretion | 7.171646e-4 |
GO:0061014 | positive regulation of mRNA catabolic process | 7.200266e-4 |
GO:0044247 | cellular polysaccharide catabolic process | 7.218923e-4 |
GO:0009251 | glucan catabolic process | 7.218923e-4 |
GO:0006783 | heme biosynthetic process | 7.247659e-4 |
GO:0002456 | T cell mediated immunity | 7.330050e-4 |
GO:0009109 | coenzyme catabolic process | 7.496320e-4 |
GO:0006749 | glutathione metabolic process | 7.530821e-4 |
GO:0000084 | S phase of mitotic cell cycle | 7.778495e-4 |
GO:0048239 | negative regulation of DNA recombination at telomere | 7.795550e-4 |
GO:0051320 | S phase | 7.834211e-4 |
GO:0050767 | regulation of neurogenesis | 7.867060e-4 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 7.961347e-4 |
GO:0001738 | morphogenesis of a polarized epithelium | 8.026380e-4 |
GO:0009394 | 2'-deoxyribonucleotide metabolic process | 8.056879e-4 |
GO:0045471 | response to ethanol | 8.164649e-4 |
GO:0051961 | negative regulation of nervous system development | 8.316050e-4 |
GO:0010742 | macrophage derived foam cell differentiation | 8.331190e-4 |
GO:0048773 | erythrophore differentiation | 8.331190e-4 |
GO:0034021 | response to silicon dioxide | 8.331190e-4 |
GO:0003069 | vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure | 8.331190e-4 |
GO:0001315 | age-dependent response to reactive oxygen species | 8.331190e-4 |
GO:0045084 | positive regulation of interleukin-12 biosynthetic process | 8.392905e-4 |
GO:0046148 | pigment biosynthetic process | 8.504187e-4 |
GO:0006986 | response to unfolded protein | 8.526403e-4 |
GO:0072668 | tubulin complex biogenesis | 8.697396e-4 |
GO:0060088 | auditory receptor cell stereocilium organization | 8.793131e-4 |
GO:0007253 | cytoplasmic sequestering of NF-kappaB | 8.876815e-4 |
GO:0003181 | atrioventricular valve morphogenesis | 8.947012e-4 |
GO:0014054 | positive regulation of gamma-aminobutyric acid secretion | 9.053008e-4 |
GO:0007096 | regulation of exit from mitosis | 9.066253e-4 |
GO:0033189 | response to vitamin A | 9.087525e-4 |
GO:0002693 | positive regulation of cellular extravasation | 9.110114e-4 |
GO:0001707 | mesoderm formation | 9.306421e-4 |
GO:0070228 | regulation of lymphocyte apoptosis | 9.395434e-4 |
GO:0002407 | dendritic cell chemotaxis | 9.598353e-4 |
GO:0061013 | regulation of mRNA catabolic process | 9.851503e-4 |
GO:0002072 | optic cup morphogenesis involved in camera-type eye development | 1.023420e-3 |
GO:0018993 | somatic sex determination | 1.031681e-3 |
GO:0010890 | positive regulation of sequestering of triglyceride | 1.031681e-3 |
GO:0061017 | hepatoblast differentiation | 1.048697e-3 |
GO:0045199 | maintenance of epithelial cell apical/basal polarity | 1.048697e-3 |
GO:0045830 | positive regulation of isotype switching | 1.054908e-3 |
GO:2000242 | negative regulation of reproductive process | 1.068774e-3 |
GO:0034763 | negative regulation of transmembrane transport | 1.083022e-3 |
GO:0003309 | type B pancreatic cell differentiation | 1.102184e-3 |
GO:0002883 | regulation of hypersensitivity | 1.115067e-3 |
GO:0009057 | macromolecule catabolic process | 1.115623e-3 |
GO:0051897 | positive regulation of protein kinase B signaling cascade | 1.132620e-3 |
GO:0006271 | DNA strand elongation involved in DNA replication | 1.135527e-3 |
GO:0048854 | brain morphogenesis | 1.140018e-3 |
GO:0061048 | negative regulation of branching involved in lung morphogenesis | 1.148372e-3 |
GO:0060695 | negative regulation of cholesterol transporter activity | 1.148372e-3 |
GO:0001812 | positive regulation of type I hypersensitivity | 1.148372e-3 |
GO:0042308 | negative regulation of protein import into nucleus | 1.173611e-3 |
GO:0044403 | symbiosis, encompassing mutualism through parasitism | 1.181689e-3 |
GO:0002074 | extraocular skeletal muscle development | 1.192138e-3 |
GO:0033344 | cholesterol efflux | 1.203081e-3 |
GO:0050884 | neuromuscular process controlling posture | 1.203629e-3 |
GO:0048266 | behavioral response to pain | 1.203629e-3 |
GO:0032796 | uropod organization | 1.203903e-3 |
GO:0048298 | positive regulation of isotype switching to IgA isotypes | 1.226007e-3 |
GO:0035356 | cellular triglyceride homeostasis | 1.233947e-3 |
GO:0043132 | NAD transport | 1.233947e-3 |
GO:0030421 | defecation | 1.233947e-3 |
GO:0001736 | establishment of planar polarity | 1.247938e-3 |
GO:0051607 | defense response to virus | 1.248004e-3 |
GO:0016571 | histone methylation | 1.253054e-3 |
GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity | 1.257534e-3 |
GO:0033032 | regulation of myeloid cell apoptosis | 1.270360e-3 |
GO:0032495 | response to muramyl dipeptide | 1.294728e-3 |
GO:0043316 | cytotoxic T cell degranulation | 1.299386e-3 |
GO:0048332 | mesoderm morphogenesis | 1.394434e-3 |
GO:0010812 | negative regulation of cell-substrate adhesion | 1.396901e-3 |
GO:0031115 | negative regulation of microtubule polymerization | 1.403818e-3 |
GO:0045872 | positive regulation of rhodopsin gene expression | 1.424896e-3 |
GO:0010883 | regulation of lipid storage | 1.431940e-3 |
GO:0007406 | negative regulation of neuroblast proliferation | 1.442348e-3 |
GO:0032633 | interleukin-4 production | 1.452822e-3 |
GO:0001865 | NK T cell differentiation | 1.452822e-3 |
GO:0045414 | regulation of interleukin-8 biosynthetic process | 1.453010e-3 |
GO:0071824 | protein-DNA complex subunit organization | 1.489058e-3 |
GO:0046784 | intronless viral mRNA export from host nucleus | 1.496627e-3 |
GO:0033628 | regulation of cell adhesion mediated by integrin | 1.498379e-3 |
GO:0048011 | nerve growth factor receptor signaling pathway | 1.499926e-3 |
GO:0006527 | arginine catabolic process | 1.503143e-3 |
GO:0007264 | small GTPase mediated signal transduction | 1.525739e-3 |
GO:0071549 | cellular response to dexamethasone stimulus | 1.531643e-3 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 1.563741e-3 |
GO:0033089 | positive regulation of T cell differentiation in thymus | 1.626486e-3 |
GO:0002885 | positive regulation of hypersensitivity | 1.626486e-3 |
GO:0002891 | positive regulation of immunoglobulin mediated immune response | 1.655979e-3 |
GO:0032008 | positive regulation of TOR signaling cascade | 1.667256e-3 |
GO:0005977 | glycogen metabolic process | 1.685284e-3 |
GO:0051220 | cytoplasmic sequestering of protein | 1.685578e-3 |
GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis | 1.685676e-3 |
GO:0034614 | cellular response to reactive oxygen species | 1.686736e-3 |
GO:0050435 | beta-amyloid metabolic process | 1.690075e-3 |
GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development | 1.693151e-3 |
GO:0003061 | positive regulation of the force of heart contraction by norepinephrine | 1.693151e-3 |
GO:2000833 | positive regulation of steroid hormone secretion | 1.694158e-3 |
GO:0060117 | auditory receptor cell development | 1.709787e-3 |
GO:0045299 | otolith mineralization | 1.711873e-3 |
GO:0032790 | ribosome disassembly | 1.711873e-3 |
GO:0048147 | negative regulation of fibroblast proliferation | 1.736481e-3 |
GO:0022415 | viral reproductive process | 1.739717e-3 |
GO:0060601 | lateral sprouting from an epithelium | 1.741729e-3 |
GO:0060326 | cell chemotaxis | 1.747773e-3 |
GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I | 1.785652e-3 |
GO:0003272 | endocardial cushion formation | 1.785652e-3 |
GO:0007021 | tubulin complex assembly | 1.785652e-3 |
GO:0002093 | auditory receptor cell morphogenesis | 1.806007e-3 |
GO:0060324 | face development | 1.829071e-3 |
GO:0034440 | lipid oxidation | 1.839111e-3 |
GO:0021892 | cerebral cortex GABAergic interneuron differentiation | 1.843228e-3 |
GO:0050706 | regulation of interleukin-1 beta secretion | 1.849233e-3 |
GO:0030237 | female sex determination | 1.876097e-3 |
GO:0007499 | ectoderm and mesoderm interaction | 1.876097e-3 |
GO:0071379 | cellular response to prostaglandin stimulus | 1.884715e-3 |
GO:0010722 | regulation of ferrochelatase activity | 1.886972e-3 |
GO:0015734 | taurine transport | 1.886972e-3 |
GO:0006848 | pyruvate transport | 1.886972e-3 |
GO:0045599 | negative regulation of fat cell differentiation | 1.887899e-3 |
GO:0048280 | vesicle fusion with Golgi apparatus | 1.909409e-3 |
GO:0071044 | histone mRNA catabolic process | 1.914263e-3 |
GO:0002864 | regulation of acute inflammatory response to antigenic stimulus | 1.922769e-3 |
GO:0044236 | multicellular organismal metabolic process | 1.982502e-3 |
GO:0007346 | regulation of mitotic cell cycle | 1.988957e-3 |
GO:0010042 | response to manganese ion | 1.996661e-3 |
GO:0070206 | protein trimerization | 2.059325e-3 |
GO:0045163 | clustering of voltage-gated potassium channels | 2.122779e-3 |
GO:0050704 | regulation of interleukin-1 secretion | 2.158888e-3 |
GO:0012501 | programmed cell death | 2.162106e-3 |
GO:0061011 | hepatic duct development | 2.163848e-3 |
GO:0008334 | histone mRNA metabolic process | 2.202302e-3 |
GO:0010043 | response to zinc ion | 2.215583e-3 |
GO:0010948 | negative regulation of cell cycle process | 2.234813e-3 |
GO:0035625 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway | 2.242800e-3 |
GO:0000910 | cytokinesis | 2.263193e-3 |
GO:0032863 | activation of Rac GTPase activity | 2.319348e-3 |
GO:0043029 | T cell homeostasis | 2.326813e-3 |
GO:0044259 | multicellular organismal macromolecule metabolic process | 2.335726e-3 |
GO:0006915 | apoptosis | 2.347176e-3 |
GO:0010763 | positive regulation of fibroblast migration | 2.357961e-3 |
GO:0016570 | histone modification | 2.375844e-3 |
GO:0032376 | positive regulation of cholesterol transport | 2.376878e-3 |
GO:0006518 | peptide metabolic process | 2.381626e-3 |
GO:0051534 | negative regulation of NFAT protein import into nucleus | 2.395305e-3 |
GO:0060197 | cloacal septation | 2.411659e-3 |
GO:0010901 | regulation of very-low-density lipoprotein particle remodeling | 2.411659e-3 |
GO:0043588 | skin development | 2.427346e-3 |
GO:0035993 | deltoid tuberosity development | 2.449116e-3 |
GO:0034341 | response to interferon-gamma | 2.469370e-3 |
GO:0015816 | glycine transport | 2.481306e-3 |
GO:0051881 | regulation of mitochondrial membrane potential | 2.493989e-3 |
GO:0007130 | synaptonemal complex assembly | 2.498241e-3 |
GO:0071482 | cellular response to light stimulus | 2.573008e-3 |
GO:0002706 | regulation of lymphocyte mediated immunity | 2.581311e-3 |
GO:0050765 | negative regulation of phagocytosis | 2.598806e-3 |
GO:0014826 | vein smooth muscle contraction | 2.598806e-3 |
GO:0060026 | convergent extension | 2.607515e-3 |
GO:0010888 | negative regulation of lipid storage | 2.616608e-3 |
GO:0000154 | rRNA modification | 2.662756e-3 |
GO:0007004 | telomere maintenance via telomerase | 2.701862e-3 |
GO:0023056 | positive regulation of signaling | 2.712935e-3 |
GO:0071985 | multivesicular body sorting pathway | 2.750087e-3 |
GO:0034728 | nucleosome organization | 2.768391e-3 |
GO:0030823 | regulation of cGMP metabolic process | 2.770183e-3 |
GO:0006479 | protein methylation | 2.785660e-3 |
GO:0072144 | glomerular mesangial cell development | 2.797931e-3 |
GO:0072011 | glomerular endothelium development | 2.797931e-3 |
GO:0060035 | notochord cell development | 2.797931e-3 |
GO:0007192 | activation of adenylate cyclase activity by serotonin receptor signaling pathway | 2.797931e-3 |
GO:0060325 | face morphogenesis | 2.826569e-3 |
GO:0010647 | positive regulation of cell communication | 2.833092e-3 |
GO:0060022 | hard palate development | 2.837610e-3 |
GO:0014013 | regulation of gliogenesis | 2.839903e-3 |
GO:0051568 | histone H3-K4 methylation | 2.844326e-3 |
GO:0060253 | negative regulation of glial cell proliferation | 2.858853e-3 |
GO:0034969 | histone arginine methylation | 2.909529e-3 |
GO:0042347 | negative regulation of NF-kappaB import into nucleus | 2.914301e-3 |
GO:0000226 | microtubule cytoskeleton organization | 2.925936e-3 |
GO:0002866 | positive regulation of acute inflammatory response to antigenic stimulus | 2.931904e-3 |
GO:0023019 | signal transduction involved in regulation of gene expression | 2.936379e-3 |
GO:0048850 | hypophysis morphogenesis | 2.952342e-3 |
GO:0043217 | myelin maintenance | 2.960573e-3 |
GO:0060751 | branch elongation involved in mammary gland duct branching | 3.030706e-3 |
GO:0006073 | cellular glucan metabolic process | 3.070294e-3 |
GO:0042254 | ribosome biogenesis | 3.085198e-3 |
GO:0071356 | cellular response to tumor necrosis factor | 3.086022e-3 |
GO:0061325 | cell proliferation involved in outflow tract morphogenesis | 3.107318e-3 |
GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis | 3.107318e-3 |
GO:0060127 | prolactin secreting cell differentiation | 3.107318e-3 |
GO:0035924 | cellular response to vascular endothelial growth factor stimulus | 3.160627e-3 |
GO:0006066 | alcohol metabolic process | 3.169493e-3 |
GO:0046112 | nucleobase biosynthetic process | 3.191481e-3 |
GO:0010833 | telomere maintenance via telomere lengthening | 3.206771e-3 |
GO:0016569 | covalent chromatin modification | 3.231107e-3 |
GO:0045604 | regulation of epidermal cell differentiation | 3.286738e-3 |
GO:0033026 | negative regulation of mast cell apoptosis | 3.351137e-3 |
GO:0072553 | terminal button organization | 3.379012e-3 |
GO:0061050 | regulation of cell growth involved in cardiac muscle cell development | 3.384814e-3 |
GO:0000093 | mitotic telophase | 3.392037e-3 |
GO:0002513 | tolerance induction to self antigen | 3.423640e-3 |
GO:0043519 | regulation of myosin II filament organization | 3.426144e-3 |
GO:0042440 | pigment metabolic process | 3.465449e-3 |
GO:0048319 | axial mesoderm morphogenesis | 3.514481e-3 |
GO:0010523 | negative regulation of calcium ion transport into cytosol | 3.514481e-3 |
GO:0046110 | xanthine metabolic process | 3.523191e-3 |
GO:0048841 | regulation of axon extension involved in axon guidance | 3.541012e-3 |
GO:0055025 | positive regulation of cardiac muscle tissue development | 3.580077e-3 |
GO:0002418 | immune response to tumor cell | 3.620354e-3 |
GO:0019377 | glycolipid catabolic process | 3.621720e-3 |
GO:0045839 | negative regulation of mitosis | 3.635643e-3 |
GO:0051289 | protein homotetramerization | 3.662991e-3 |
GO:0006325 | chromatin organization | 3.713938e-3 |
GO:0034694 | response to prostaglandin stimulus | 3.734729e-3 |
GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation | 3.754898e-3 |
GO:0045911 | positive regulation of DNA recombination | 3.792391e-3 |
GO:0006817 | phosphate ion transport | 3.817025e-3 |
GO:0060561 | apoptosis involved in morphogenesis | 3.819760e-3 |
GO:0046578 | regulation of Ras protein signal transduction | 3.837782e-3 |
GO:0032851 | positive regulation of Rab GTPase activity | 3.843445e-3 |
GO:0042424 | catecholamine catabolic process | 3.924947e-3 |
GO:0030509 | BMP signaling pathway | 3.967184e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0071870 | cellular response to catecholamine stimulus | 1.674343e-12 |
GO:0071874 | cellular response to norepinephrine stimulus | 2.396422e-11 |
GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB cascade | 3.138666e-10 |
GO:0031055 | chromatin remodeling at centromere | 1.713197e-8 |
GO:0060461 | right lung morphogenesis | 4.053559e-8 |
GO:0090131 | mesenchyme migration | 4.053559e-8 |
GO:0060446 | branching involved in open tracheal system development | 4.053559e-8 |
GO:0014822 | detection of wounding | 4.053559e-8 |
GO:0048371 | lateral mesodermal cell differentiation | 4.053559e-8 |
GO:0048613 | embryonic ectodermal digestive tract morphogenesis | 4.053559e-8 |
GO:0048566 | embryonic digestive tract development | 4.515185e-8 |
GO:0045814 | negative regulation of gene expression, epigenetic | 6.403893e-8 |
GO:0070245 | positive regulation of thymocyte apoptosis | 8.155481e-8 |
GO:0007044 | cell-substrate junction assembly | 8.759291e-8 |
GO:0070234 | positive regulation of T cell apoptosis | 1.328265e-7 |
GO:0009303 | rRNA transcription | 2.127390e-7 |
GO:0019060 | intracellular transport of viral proteins in host cell | 2.223967e-7 |
GO:0046967 | cytosol to ER transport | 2.223967e-7 |
GO:0000238 | zygotene | 3.999134e-7 |
GO:0060948 | cardiac vascular smooth muscle cell development | 5.196099e-7 |
GO:0003281 | ventricular septum development | 5.215539e-7 |
GO:0032606 | type I interferon production | 5.915518e-7 |
GO:0070243 | regulation of thymocyte apoptosis | 6.721793e-7 |
GO:0046485 | ether lipid metabolic process | 9.755894e-7 |
GO:0070232 | regulation of T cell apoptosis | 1.064831e-6 |
GO:0033085 | negative regulation of T cell differentiation in thymus | 1.497503e-6 |
GO:0002792 | negative regulation of peptide secretion | 1.510115e-6 |
GO:0000165 | MAPKKK cascade | 1.699809e-6 |
GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway | 2.196196e-6 |
GO:0060458 | right lung development | 2.465484e-6 |
GO:0014819 | regulation of skeletal muscle contraction | 2.906416e-6 |
GO:0033993 | response to lipid | 3.220500e-6 |
GO:0045580 | regulation of T cell differentiation | 3.504104e-6 |
GO:0030818 | negative regulation of cAMP biosynthetic process | 3.573931e-6 |
GO:0034329 | cell junction assembly | 3.575322e-6 |
GO:0048240 | sperm capacitation | 3.688100e-6 |
GO:0097107 | postsynaptic density assembly | 4.862346e-6 |
GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity | 4.862346e-6 |
GO:0032765 | positive regulation of mast cell cytokine production | 4.862346e-6 |
GO:0002431 | Fc receptor mediated stimulatory signaling pathway | 4.862346e-6 |
GO:0045060 | negative thymic T cell selection | 5.389524e-6 |
GO:0097084 | vascular smooth muscle cell development | 6.178549e-6 |
GO:0002649 | regulation of tolerance induction to self antigen | 6.204285e-6 |
GO:0033081 | regulation of T cell differentiation in thymus | 6.441740e-6 |
GO:0002885 | positive regulation of hypersensitivity | 6.816704e-6 |
GO:0034330 | cell junction organization | 7.201167e-6 |
GO:0007183 | SMAD protein complex assembly | 7.647157e-6 |
GO:2000108 | positive regulation of leukocyte apoptosis | 8.031377e-6 |
GO:0031508 | centromeric heterochromatin formation | 8.308650e-6 |
GO:0007243 | intracellular protein kinase cascade | 9.025837e-6 |
GO:0033026 | negative regulation of mast cell apoptosis | 9.089057e-6 |
GO:0002863 | positive regulation of inflammatory response to antigenic stimulus | 9.588584e-6 |
GO:0000187 | activation of MAPK activity | 1.091371e-5 |
GO:0045351 | type I interferon biosynthetic process | 1.181233e-5 |
GO:2000377 | regulation of reactive oxygen species metabolic process | 1.211363e-5 |
GO:0045980 | negative regulation of nucleotide metabolic process | 1.283283e-5 |
GO:0009988 | cell-cell recognition | 1.290535e-5 |
GO:0003279 | cardiac septum development | 1.344633e-5 |
GO:0031448 | positive regulation of fast-twitch skeletal muscle fiber contraction | 1.503477e-5 |
GO:0006473 | protein acetylation | 1.806055e-5 |
GO:2000106 | regulation of leukocyte apoptosis | 1.991878e-5 |
GO:0090278 | negative regulation of peptide hormone secretion | 2.308292e-5 |
GO:0051043 | regulation of membrane protein ectodomain proteolysis | 2.536567e-5 |
GO:0021918 | regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment | 2.709314e-5 |
GO:0021905 | forebrain-midbrain boundary formation | 2.709314e-5 |
GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain | 2.709314e-5 |
GO:0003322 | pancreatic A cell development | 2.709314e-5 |
GO:0006342 | chromatin silencing | 2.817781e-5 |
GO:0046638 | positive regulation of alpha-beta T cell differentiation | 3.221586e-5 |
GO:0060977 | coronary vasculature morphogenesis | 3.287492e-5 |
GO:0070230 | positive regulation of lymphocyte apoptosis | 3.405586e-5 |
GO:0006970 | response to osmotic stress | 3.516998e-5 |
GO:2000653 | regulation of genetic imprinting | 3.672006e-5 |
GO:0043252 | sodium-independent organic anion transport | 3.672006e-5 |
GO:0045198 | establishment of epithelial cell apical/basal polarity | 3.838667e-5 |
GO:0046124 | purine deoxyribonucleoside catabolic process | 3.857306e-5 |
GO:0001778 | plasma membrane repair | 3.864792e-5 |
GO:0043383 | negative T cell selection | 4.024714e-5 |
GO:0048170 | positive regulation of long-term neuronal synaptic plasticity | 4.107387e-5 |
GO:0032148 | activation of protein kinase B activity | 4.153380e-5 |
GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 4.298311e-5 |
GO:0090042 | tubulin deacetylation | 4.500819e-5 |
GO:0070846 | Hsp90 deacetylation | 4.500819e-5 |
GO:0019882 | antigen processing and presentation | 4.581873e-5 |
GO:0043525 | positive regulation of neuron apoptosis | 5.031895e-5 |
GO:0046676 | negative regulation of insulin secretion | 5.060579e-5 |
GO:0070301 | cellular response to hydrogen peroxide | 5.477781e-5 |
GO:0034508 | centromere complex assembly | 5.758335e-5 |
GO:0090316 | positive regulation of intracellular protein transport | 6.426036e-5 |
GO:0003289 | atrial septum primum morphogenesis | 6.471706e-5 |
GO:0021773 | striatal medium spiny neuron differentiation | 6.612153e-5 |
GO:0008631 | induction of apoptosis by oxidative stress | 6.612153e-5 |
GO:0048557 | embryonic digestive tract morphogenesis | 6.671332e-5 |
GO:0046373 | L-arabinose metabolic process | 7.784024e-5 |
GO:0035625 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway | 8.070097e-5 |
GO:0046637 | regulation of alpha-beta T cell differentiation | 8.151757e-5 |
GO:0042307 | positive regulation of protein import into nucleus | 8.170027e-5 |
GO:0033025 | regulation of mast cell apoptosis | 8.925959e-5 |
GO:0002864 | regulation of acute inflammatory response to antigenic stimulus | 8.929671e-5 |
GO:0045627 | positive regulation of T-helper 1 cell differentiation | 9.245850e-5 |
GO:0002883 | regulation of hypersensitivity | 9.703136e-5 |
GO:0071407 | cellular response to organic cyclic compound | 9.782421e-5 |
GO:0042306 | regulation of protein import into nucleus | 9.942629e-5 |
GO:0002866 | positive regulation of acute inflammatory response to antigenic stimulus | 1.006352e-4 |
GO:0051222 | positive regulation of protein transport | 1.061832e-4 |
GO:0045061 | thymic T cell selection | 1.078652e-4 |
GO:0006538 | glutamate catabolic process | 1.135336e-4 |
GO:0000387 | spliceosomal snRNP assembly | 1.135408e-4 |
GO:0021796 | cerebral cortex regionalization | 1.135408e-4 |
GO:0007339 | binding of sperm to zona pellucida | 1.170678e-4 |
GO:0060412 | ventricular septum morphogenesis | 1.261903e-4 |
GO:0060425 | lung morphogenesis | 1.288887e-4 |
GO:0046121 | deoxyribonucleoside catabolic process | 1.343864e-4 |
GO:0034764 | positive regulation of transmembrane transport | 1.363478e-4 |
GO:0002861 | regulation of inflammatory response to antigenic stimulus | 1.386996e-4 |
GO:0043305 | negative regulation of mast cell degranulation | 1.396256e-4 |
GO:0042401 | cellular biogenic amine biosynthetic process | 1.437257e-4 |
GO:0090076 | relaxation of skeletal muscle | 1.513966e-4 |
GO:0032470 | elevation of endoplasmic reticulum calcium ion concentration | 1.513966e-4 |
GO:0002250 | adaptive immune response | 1.575178e-4 |
GO:0045582 | positive regulation of T cell differentiation | 1.594537e-4 |
GO:0006346 | methylation-dependent chromatin silencing | 1.612302e-4 |
GO:0048041 | focal adhesion assembly | 1.662524e-4 |
GO:0003183 | mitral valve morphogenesis | 1.687366e-4 |
GO:0043543 | protein acylation | 1.700665e-4 |
GO:0071882 | activation of phospholipase C activity by adrenergic receptor signaling pathway | 1.703301e-4 |
GO:0071881 | inhibition of adenylate cyclase activity by adrenergic receptor signaling pathway | 1.703301e-4 |
GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway | 1.722767e-4 |
GO:0040029 | regulation of gene expression, epigenetic | 1.761840e-4 |
GO:0051044 | positive regulation of membrane protein ectodomain proteolysis | 1.786003e-4 |
GO:0002673 | regulation of acute inflammatory response | 1.789815e-4 |
GO:0006930 | substrate-dependent cell migration, cell extension | 1.824943e-4 |
GO:0045065 | cytotoxic T cell differentiation | 1.832404e-4 |
GO:0006475 | internal protein amino acid acetylation | 1.836949e-4 |
GO:0046165 | alcohol biosynthetic process | 1.849725e-4 |
GO:0046173 | polyol biosynthetic process | 1.931099e-4 |
GO:0033617 | mitochondrial respiratory chain complex IV assembly | 2.014318e-4 |
GO:0007224 | smoothened signaling pathway | 2.073311e-4 |
GO:0045619 | regulation of lymphocyte differentiation | 2.117773e-4 |
GO:0051659 | maintenance of mitochondrion location | 2.121358e-4 |
GO:0045358 | negative regulation of interferon-beta biosynthetic process | 2.168786e-4 |
GO:0021539 | subthalamus development | 2.234190e-4 |
GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process | 2.234190e-4 |
GO:0071418 | cellular response to amine stimulus | 2.239820e-4 |
GO:0014009 | glial cell proliferation | 2.293569e-4 |
GO:0006044 | N-acetylglucosamine metabolic process | 2.293569e-4 |
GO:0006540 | glutamate decarboxylation to succinate | 2.420344e-4 |
GO:0060563 | neuroepithelial cell differentiation | 2.665205e-4 |
GO:0034502 | protein localization to chromosome | 2.683848e-4 |
GO:0042089 | cytokine biosynthetic process | 2.720443e-4 |
GO:0021877 | forebrain neuron fate commitment | 2.843969e-4 |
GO:0033157 | regulation of intracellular protein transport | 2.932413e-4 |
GO:0060463 | lung lobe morphogenesis | 2.942521e-4 |
GO:0090035 | positive regulation of cellular chaperone-mediated protein complex assembly | 2.986606e-4 |
GO:0050689 | negative regulation of defense response to virus by host | 2.986606e-4 |
GO:0018158 | protein oxidation | 2.986606e-4 |
GO:0002891 | positive regulation of immunoglobulin mediated immune response | 3.025459e-4 |
GO:2000677 | regulation of transcription regulatory region DNA binding | 3.036878e-4 |
GO:0071417 | cellular response to organic nitrogen | 3.050997e-4 |
GO:0045058 | T cell selection | 3.054793e-4 |
GO:2000379 | positive regulation of reactive oxygen species metabolic process | 3.061743e-4 |
GO:0000460 | maturation of 5.8S rRNA | 3.080829e-4 |
GO:0045581 | negative regulation of T cell differentiation | 3.128827e-4 |
GO:0046635 | positive regulation of alpha-beta T cell activation | 3.146572e-4 |
GO:0051956 | negative regulation of amino acid transport | 3.241945e-4 |
GO:0002922 | positive regulation of humoral immune response | 3.318224e-4 |
GO:0001709 | cell fate determination | 3.483536e-4 |
GO:0021798 | forebrain dorsal/ventral pattern formation | 3.489286e-4 |
GO:0050854 | regulation of antigen receptor-mediated signaling pathway | 3.497896e-4 |
GO:0007288 | sperm axoneme assembly | 3.644494e-4 |
GO:0060161 | positive regulation of dopamine receptor signaling pathway | 3.750796e-4 |
GO:0009817 | defense response to fungus, incompatible interaction | 3.821769e-4 |
GO:0071316 | cellular response to nicotine | 3.852026e-4 |
GO:0071385 | cellular response to glucocorticoid stimulus | 3.875213e-4 |
GO:0007406 | negative regulation of neuroblast proliferation | 3.929334e-4 |
GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation | 4.031115e-4 |
GO:0042421 | norepinephrine biosynthetic process | 4.031115e-4 |
GO:0006378 | mRNA polyadenylation | 4.046662e-4 |
GO:0018206 | peptidyl-methionine modification | 4.204434e-4 |
GO:0018394 | peptidyl-lysine acetylation | 4.610248e-4 |
GO:0051054 | positive regulation of DNA metabolic process | 4.676872e-4 |
GO:0032846 | positive regulation of homeostatic process | 4.716473e-4 |
GO:0060022 | hard palate development | 5.064240e-4 |
GO:0072404 | signal transduction involved in G1/S transition checkpoint | 5.078487e-4 |
GO:0034616 | response to laminar fluid shear stress | 5.078487e-4 |
GO:0051101 | regulation of DNA binding | 5.113318e-4 |
GO:0034614 | cellular response to reactive oxygen species | 5.126985e-4 |
GO:0002675 | positive regulation of acute inflammatory response | 5.139955e-4 |
GO:0008625 | induction of apoptosis via death domain receptors | 5.216402e-4 |
GO:0032740 | positive regulation of interleukin-17 production | 5.376439e-4 |
GO:0032388 | positive regulation of intracellular transport | 5.497582e-4 |
GO:0035036 | sperm-egg recognition | 5.503174e-4 |
GO:0040034 | regulation of development, heterochronic | 5.644324e-4 |
GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis | 5.680311e-4 |
GO:0071222 | cellular response to lipopolysaccharide | 6.170020e-4 |
GO:0007254 | JNK cascade | 6.286995e-4 |
GO:0072395 | signal transduction involved in cell cycle checkpoint | 6.295672e-4 |
GO:0045740 | positive regulation of DNA replication | 6.314248e-4 |
GO:0033077 | T cell differentiation in thymus | 6.346873e-4 |
GO:0003211 | cardiac ventricle formation | 6.395392e-4 |
GO:0000281 | cytokinesis after mitosis | 6.427828e-4 |
GO:0034509 | centromeric core chromatin assembly | 6.519733e-4 |
GO:0034080 | CenH3-containing nucleosome assembly at centromere | 6.519733e-4 |
GO:0031129 | inductive cell-cell signaling | 6.519733e-4 |
GO:0001812 | positive regulation of type I hypersensitivity | 6.520317e-4 |
GO:0007286 | spermatid development | 6.543803e-4 |
GO:0006568 | tryptophan metabolic process | 6.566946e-4 |
GO:0018393 | internal peptidyl-lysine acetylation | 6.627981e-4 |
GO:2000779 | regulation of double-strand break repair | 6.635670e-4 |
GO:0001738 | morphogenesis of a polarized epithelium | 6.645067e-4 |
GO:0033160 | positive regulation of protein import into nucleus, translocation | 6.673805e-4 |
GO:0016573 | histone acetylation | 6.687101e-4 |
GO:0008643 | carbohydrate transport | 6.787839e-4 |
GO:0003215 | cardiac right ventricle morphogenesis | 6.800942e-4 |
GO:0097022 | lymphocyte migration into lymph node | 7.094565e-4 |
GO:0072610 | interleukin-12 secretion | 7.094565e-4 |
GO:0045596 | negative regulation of cell differentiation | 7.179547e-4 |
GO:0030217 | T cell differentiation | 7.203748e-4 |
GO:0048535 | lymph node development | 7.265590e-4 |
GO:0033205 | cell cycle cytokinesis | 7.291102e-4 |
GO:0060407 | negative regulation of penile erection | 7.324898e-4 |
GO:0060169 | negative regulation of adenosine receptor signaling pathway | 7.324898e-4 |
GO:2000256 | positive regulation of male germ cell proliferation | 7.324898e-4 |
GO:0046111 | xanthine biosynthetic process | 7.324898e-4 |
GO:0072355 | histone H3-T3 phosphorylation | 7.324898e-4 |
GO:0015739 | sialic acid transport | 7.324898e-4 |
GO:0002314 | germinal center B cell differentiation | 7.324898e-4 |
GO:0006157 | deoxyadenosine catabolic process | 7.324898e-4 |
GO:0009637 | response to blue light | 7.324898e-4 |
GO:0042231 | interleukin-13 biosynthetic process | 7.324898e-4 |
GO:0046061 | dATP catabolic process | 7.324898e-4 |
GO:0090086 | negative regulation of protein deubiquitination | 7.426680e-4 |
GO:0046888 | negative regulation of hormone secretion | 7.503156e-4 |
GO:0044283 | small molecule biosynthetic process | 7.535892e-4 |
GO:2000172 | regulation of branching morphogenesis of a nerve | 7.721949e-4 |
GO:0019441 | tryptophan catabolic process to kynurenine | 7.725829e-4 |
GO:0060411 | cardiac septum morphogenesis | 8.183919e-4 |
GO:0048505 | regulation of timing of cell differentiation | 8.350406e-4 |
GO:0042761 | very long-chain fatty acid biosynthetic process | 8.422990e-4 |
GO:0048515 | spermatid differentiation | 8.472294e-4 |
GO:0070542 | response to fatty acid | 8.625528e-4 |
GO:0033037 | polysaccharide localization | 8.637606e-4 |
GO:0048002 | antigen processing and presentation of peptide antigen | 8.797899e-4 |
GO:0002518 | lymphocyte chemotaxis across high endothelial venule | 8.821966e-4 |
GO:0003207 | cardiac chamber formation | 8.850036e-4 |
GO:0050428 | 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process | 9.142626e-4 |
GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification | 9.237946e-4 |
GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II | 9.266302e-4 |
GO:0021983 | pituitary gland development | 9.276502e-4 |
GO:0032760 | positive regulation of tumor necrosis factor production | 9.407132e-4 |
GO:0043304 | regulation of mast cell degranulation | 9.575863e-4 |
GO:0070228 | regulation of lymphocyte apoptosis | 1.002533e-3 |
GO:0033132 | negative regulation of glucokinase activity | 1.010893e-3 |
GO:0048568 | embryonic organ development | 1.010913e-3 |
GO:0051657 | maintenance of organelle location | 1.015393e-3 |
GO:2000822 | regulation of behavioral fear response | 1.019130e-3 |
GO:2000429 | negative regulation of neutrophil aggregation | 1.024991e-3 |
GO:0071638 | negative regulation of monocyte chemotactic protein-1 production | 1.024991e-3 |
GO:2000469 | negative regulation of peroxidase activity | 1.024991e-3 |
GO:0000027 | ribosomal large subunit assembly | 1.024991e-3 |
GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase | 1.024991e-3 |
GO:0035726 | common myeloid progenitor cell proliferation | 1.024991e-3 |
GO:0018205 | peptidyl-lysine modification | 1.069688e-3 |
GO:0045006 | DNA deamination | 1.070862e-3 |
GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification | 1.070862e-3 |
GO:0051052 | regulation of DNA metabolic process | 1.074163e-3 |
GO:0017004 | cytochrome complex assembly | 1.099198e-3 |
GO:0019049 | evasion of host defenses by virus | 1.099198e-3 |
GO:0080164 | regulation of nitric oxide metabolic process | 1.104933e-3 |
GO:0060112 | generation of ovulation cycle rhythm | 1.104933e-3 |
GO:0001988 | positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure | 1.104933e-3 |
GO:0031347 | regulation of defense response | 1.109710e-3 |
GO:0042107 | cytokine metabolic process | 1.115318e-3 |
GO:0042538 | hyperosmotic salinity response | 1.126989e-3 |
GO:0090322 | regulation of superoxide metabolic process | 1.133718e-3 |
GO:0072091 | regulation of stem cell proliferation | 1.135885e-3 |
GO:0097026 | dendritic cell dendrite assembly | 1.136594e-3 |
GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion | 1.136594e-3 |
GO:0006275 | regulation of DNA replication | 1.155035e-3 |
GO:0043434 | response to peptide hormone stimulus | 1.172364e-3 |
GO:0003357 | noradrenergic neuron differentiation | 1.220941e-3 |
GO:0071479 | cellular response to ionizing radiation | 1.230188e-3 |
GO:0006351 | transcription, DNA-dependent | 1.230317e-3 |
GO:0071779 | G1/S transition checkpoint | 1.240361e-3 |
GO:0034105 | positive regulation of tissue remodeling | 1.240361e-3 |
GO:0072539 | T-helper 17 cell differentiation | 1.243302e-3 |
GO:0045994 | positive regulation of translational initiation by iron | 1.243302e-3 |
GO:0061048 | negative regulation of branching involved in lung morphogenesis | 1.243302e-3 |
GO:0002037 | negative regulation of L-glutamate transport | 1.243302e-3 |
GO:0018199 | peptidyl-glutamine modification | 1.243302e-3 |
GO:0034116 | positive regulation of heterotypic cell-cell adhesion | 1.243302e-3 |
GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 1.277945e-3 |
GO:0032774 | RNA biosynthetic process | 1.290561e-3 |
GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.293827e-3 |
GO:0002003 | angiotensin maturation | 1.304310e-3 |
GO:2000648 | positive regulation of stem cell proliferation | 1.331177e-3 |
GO:0006955 | immune response | 1.338351e-3 |
GO:0042110 | T cell activation | 1.339017e-3 |
GO:0046634 | regulation of alpha-beta T cell activation | 1.372859e-3 |
GO:0048562 | embryonic organ morphogenesis | 1.385594e-3 |
GO:0046649 | lymphocyte activation | 1.397110e-3 |
GO:0002376 | immune system process | 1.397648e-3 |
GO:0006952 | defense response | 1.450471e-3 |
GO:0003348 | cardiac endothelial cell differentiation | 1.461635e-3 |
GO:0006633 | fatty acid biosynthetic process | 1.487369e-3 |
GO:0050995 | negative regulation of lipid catabolic process | 1.496530e-3 |
GO:0031444 | slow-twitch skeletal muscle fiber contraction | 1.557580e-3 |
GO:0002175 | protein localization to paranode region of axon | 1.557580e-3 |
GO:0045647 | negative regulation of erythrocyte differentiation | 1.557740e-3 |
GO:0032471 | reduction of endoplasmic reticulum calcium ion concentration | 1.563401e-3 |
GO:0060976 | coronary vasculature development | 1.573801e-3 |
GO:0045780 | positive regulation of bone resorption | 1.591822e-3 |
GO:0030308 | negative regulation of cell growth | 1.612529e-3 |
GO:0060413 | atrial septum morphogenesis | 1.646630e-3 |
GO:0071356 | cellular response to tumor necrosis factor | 1.672980e-3 |
GO:0045321 | leukocyte activation | 1.694386e-3 |
GO:0001819 | positive regulation of cytokine production | 1.708645e-3 |
GO:0032288 | myelin assembly | 1.734665e-3 |
GO:0007184 | SMAD protein import into nucleus | 1.734665e-3 |
GO:2000381 | negative regulation of mesoderm development | 1.754554e-3 |
GO:0010991 | negative regulation of SMAD protein complex assembly | 1.754554e-3 |
GO:0043932 | ossification involved in bone remodeling | 1.754554e-3 |
GO:0048714 | positive regulation of oligodendrocyte differentiation | 1.769526e-3 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 1.780603e-3 |
GO:0048333 | mesodermal cell differentiation | 1.807446e-3 |
GO:0031365 | N-terminal protein amino acid modification | 1.814475e-3 |
GO:0042255 | ribosome assembly | 1.841197e-3 |
GO:0032731 | positive regulation of interleukin-1 beta production | 1.845034e-3 |
GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity | 1.854758e-3 |
GO:0021978 | telencephalon regionalization | 1.854758e-3 |
GO:0000059 | protein import into nucleus, docking | 1.856809e-3 |
GO:0051823 | regulation of synapse structural plasticity | 1.862881e-3 |
GO:0071803 | positive regulation of podosome assembly | 1.866148e-3 |
GO:0035886 | vascular smooth muscle cell differentiation | 1.881073e-3 |
GO:0043392 | negative regulation of DNA binding | 1.890663e-3 |
GO:0071359 | cellular response to dsRNA | 1.909056e-3 |
GO:0009262 | deoxyribonucleotide metabolic process | 1.918582e-3 |
GO:0043406 | positive regulation of MAP kinase activity | 1.927415e-3 |
GO:0034260 | negative regulation of GTPase activity | 1.928894e-3 |
GO:0009719 | response to endogenous stimulus | 1.930673e-3 |
GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process | 1.931629e-3 |
GO:0031018 | endocrine pancreas development | 1.939571e-3 |
GO:0032844 | regulation of homeostatic process | 1.951685e-3 |
GO:0006114 | glycerol biosynthetic process | 1.965544e-3 |
GO:0010741 | negative regulation of intracellular protein kinase cascade | 1.996084e-3 |
GO:0003170 | heart valve development | 2.010005e-3 |
GO:0031324 | negative regulation of cellular metabolic process | 2.014121e-3 |
GO:0071219 | cellular response to molecule of bacterial origin | 2.077565e-3 |
GO:0090200 | positive regulation of release of cytochrome c from mitochondria | 2.078374e-3 |
GO:0009651 | response to salt stress | 2.104973e-3 |
GO:0050862 | positive regulation of T cell receptor signaling pathway | 2.113272e-3 |
GO:0090181 | regulation of cholesterol metabolic process | 2.118563e-3 |
GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 2.136951e-3 |
GO:0007352 | zygotic specification of dorsal/ventral axis | 2.164457e-3 |
GO:0090023 | positive regulation of neutrophil chemotaxis | 2.173959e-3 |
GO:0031098 | stress-activated protein kinase signaling cascade | 2.175305e-3 |
GO:0045620 | negative regulation of lymphocyte differentiation | 2.189169e-3 |
GO:0060557 | positive regulation of vitamin D biosynthetic process | 2.221441e-3 |
GO:0003290 | atrial septum secundum morphogenesis | 2.221441e-3 |
GO:0002651 | positive regulation of tolerance induction to self antigen | 2.221441e-3 |
GO:0001798 | positive regulation of type IIa hypersensitivity | 2.240318e-3 |
GO:2000758 | positive regulation of peptidyl-lysine acetylation | 2.291938e-3 |
GO:0070845 | polyubiquitinated misfolded protein transport | 2.301680e-3 |
GO:0009181 | purine ribonucleoside diphosphate catabolic process | 2.308073e-3 |
GO:0070265 | necrotic cell death | 2.308073e-3 |
GO:0009120 | deoxyribonucleoside metabolic process | 2.308073e-3 |
GO:0003195 | tricuspid valve formation | 2.308073e-3 |
GO:0030497 | fatty acid elongation | 2.330872e-3 |
GO:2000679 | positive regulation of transcription regulatory region DNA binding | 2.348813e-3 |
GO:0046822 | regulation of nucleocytoplasmic transport | 2.365769e-3 |
GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 2.374896e-3 |
GO:0015870 | acetylcholine transport | 2.410859e-3 |
GO:0006950 | response to stress | 2.435792e-3 |
GO:0035640 | exploration behavior | 2.575841e-3 |
GO:0071216 | cellular response to biotic stimulus | 2.580599e-3 |
GO:0006515 | misfolded or incompletely synthesized protein catabolic process | 2.606538e-3 |
GO:0001805 | positive regulation of type III hypersensitivity | 2.623349e-3 |
GO:0021879 | forebrain neuron differentiation | 2.634820e-3 |
GO:0060426 | lung vasculature development | 2.704671e-3 |
GO:0071549 | cellular response to dexamethasone stimulus | 2.740745e-3 |
GO:0006094 | gluconeogenesis | 2.744931e-3 |
GO:0034261 | negative regulation of Ras GTPase activity | 2.755211e-3 |
GO:0006927 | transformed cell apoptosis | 2.755211e-3 |
GO:0006105 | succinate metabolic process | 2.770577e-3 |
GO:0042254 | ribosome biogenesis | 2.819338e-3 |
GO:0032008 | positive regulation of TOR signaling cascade | 2.884895e-3 |
GO:0034625 | fatty acid elongation, monounsaturated fatty acid | 2.892925e-3 |
GO:0009892 | negative regulation of metabolic process | 2.897448e-3 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 2.931423e-3 |
GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation | 2.953969e-3 |
GO:0043654 | recognition of apoptotic cell | 2.969341e-3 |
GO:0045861 | negative regulation of proteolysis | 2.977148e-3 |
GO:0000060 | protein import into nucleus, translocation | 2.977529e-3 |
GO:0019368 | fatty acid elongation, unsaturated fatty acid | 2.998604e-3 |
GO:0032383 | regulation of intracellular cholesterol transport | 3.045271e-3 |
GO:0010826 | negative regulation of centrosome duplication | 3.045271e-3 |
GO:0002876 | positive regulation of chronic inflammatory response to antigenic stimulus | 3.052774e-3 |
GO:0001555 | oocyte growth | 3.052774e-3 |
GO:0060947 | cardiac vascular smooth muscle cell differentiation | 3.055935e-3 |
GO:0043631 | RNA polyadenylation | 3.070116e-3 |
GO:0071346 | cellular response to interferon-gamma | 3.080861e-3 |
GO:0009890 | negative regulation of biosynthetic process | 3.085213e-3 |
GO:0003231 | cardiac ventricle development | 3.087843e-3 |
GO:0010758 | regulation of macrophage chemotaxis | 3.096068e-3 |
GO:2000412 | positive regulation of thymocyte migration | 3.166789e-3 |
GO:0002449 | lymphocyte mediated immunity | 3.222340e-3 |
GO:0007256 | activation of JNKK activity | 3.323284e-3 |
GO:0001775 | cell activation | 3.354534e-3 |
GO:0045624 | positive regulation of T-helper cell differentiation | 3.399173e-3 |
GO:0007141 | male meiosis I | 3.420371e-3 |
GO:0002606 | positive regulation of dendritic cell antigen processing and presentation | 3.420371e-3 |
GO:0032732 | positive regulation of interleukin-1 production | 3.488353e-3 |
GO:2000173 | negative regulation of branching morphogenesis of a nerve | 3.489136e-3 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 3.489136e-3 |
GO:0060547 | negative regulation of necrotic cell death | 3.551089e-3 |
GO:0071218 | cellular response to misfolded protein | 3.614047e-3 |
GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development | 3.614047e-3 |
GO:0032916 | positive regulation of transforming growth factor beta3 production | 3.614047e-3 |
GO:0043011 | myeloid dendritic cell differentiation | 3.630440e-3 |
GO:0045621 | positive regulation of lymphocyte differentiation | 3.639505e-3 |
GO:0048368 | lateral mesoderm development | 3.641191e-3 |
GO:0048617 | embryonic foregut morphogenesis | 3.679138e-3 |
GO:0051856 | adhesion to symbiont | 3.684946e-3 |
GO:0003283 | atrial septum development | 3.689524e-3 |
GO:0003205 | cardiac chamber development | 3.765873e-3 |
GO:0003179 | heart valve morphogenesis | 3.784506e-3 |
GO:2000384 | negative regulation of ectoderm development | 3.801437e-3 |
GO:0032386 | regulation of intracellular transport | 3.803688e-3 |
GO:0033209 | tumor necrosis factor-mediated signaling pathway | 3.822071e-3 |
GO:0033059 | cellular pigmentation | 3.832714e-3 |
GO:0060695 | negative regulation of cholesterol transporter activity | 3.871287e-3 |
GO:0046102 | inosine metabolic process | 3.871287e-3 |
GO:0009217 | purine deoxyribonucleoside triphosphate catabolic process | 3.871287e-3 |
GO:0015759 | beta-glucoside transport | 3.871287e-3 |
GO:0070267 | oncosis | 3.925378e-3 |
GO:0019255 | glucose 1-phosphate metabolic process | 3.964491e-3 |
GO:0010457 | centriole-centriole cohesion | 3.964491e-3 |
GO:0016070 | RNA metabolic process | 3.992664e-3 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 4.031124e-3 |
GO:0045089 | positive regulation of innate immune response | 4.041069e-3 |
GO:0031349 | positive regulation of defense response | 4.053139e-3 |
GO:0046333 | octopamine metabolic process | 4.085898e-3 |
GO:0051142 | positive regulation of NK T cell proliferation | 4.085898e-3 |
GO:0042309 | homoiothermy | 4.085898e-3 |
GO:0032863 | activation of Rac GTPase activity | 4.104141e-3 |
GO:0048484 | enteric nervous system development | 4.184539e-3 |
GO:0014823 | response to activity | 4.185051e-3 |
GO:0006476 | protein deacetylation | 4.201580e-3 |
GO:0045908 | negative regulation of vasodilation | 4.226331e-3 |
GO:0045989 | positive regulation of striated muscle contraction | 4.229384e-3 |
GO:0035910 | ascending aorta morphogenesis | 4.229686e-3 |
GO:2000761 | positive regulation of N-terminal peptidyl-lysine acetylation | 4.229686e-3 |
GO:0006359 | regulation of transcription from RNA polymerase III promoter | 4.229686e-3 |
GO:0006958 | complement activation, classical pathway | 4.234093e-3 |
GO:0042345 | regulation of NF-kappaB import into nucleus | 4.246459e-3 |
GO:0006366 | transcription from RNA polymerase II promoter | 4.270504e-3 |
GO:0002763 | positive regulation of myeloid leukocyte differentiation | 4.272708e-3 |
GO:0002791 | regulation of peptide secretion | 4.313110e-3 |
GO:0045080 | positive regulation of chemokine biosynthetic process | 4.354212e-3 |
GO:0051835 | positive regulation of synapse structural plasticity | 4.412239e-3 |
GO:0002683 | negative regulation of immune system process | 4.433545e-3 |
GO:0002920 | regulation of humoral immune response | 4.506940e-3 |
GO:0035089 | establishment of apical/basal cell polarity | 4.523061e-3 |
GO:0009186 | deoxyribonucleoside diphosphate metabolic process | 4.523061e-3 |
GO:0001771 | immunological synapse formation | 4.523061e-3 |
GO:0090074 | negative regulation of protein homodimerization activity | 4.526758e-3 |
GO:0006419 | alanyl-tRNA aminoacylation | 4.526758e-3 |
GO:0046823 | negative regulation of nucleocytoplasmic transport | 4.543533e-3 |
GO:0031663 | lipopolysaccharide-mediated signaling pathway | 4.569258e-3 |
GO:0006586 | indolalkylamine metabolic process | 4.569258e-3 |
GO:0010569 | regulation of double-strand break repair via homologous recombination | 4.588147e-3 |
GO:0043331 | response to dsRNA | 4.672948e-3 |
GO:0032808 | lacrimal gland development | 4.720146e-3 |
GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus | 4.887098e-3 |
GO:0044403 | symbiosis, encompassing mutualism through parasitism | 4.929592e-3 |
GO:0050714 | positive regulation of protein secretion | 4.973205e-3 |
GO:0035601 | protein deacylation | 4.986202e-3 |
GO:0033006 | regulation of mast cell activation involved in immune response | 5.012371e-3 |
GO:0002455 | humoral immune response mediated by circulating immunoglobulin | 5.017139e-3 |
GO:0006646 | phosphatidylethanolamine biosynthetic process | 5.070984e-3 |
GO:0045625 | regulation of T-helper 1 cell differentiation | 5.070984e-3 |
GO:0009950 | dorsal/ventral axis specification | 5.123599e-3 |
GO:0050868 | negative regulation of T cell activation | 5.153732e-3 |
GO:0006576 | cellular biogenic amine metabolic process | 5.160706e-3 |
GO:0021536 | diencephalon development | 5.194502e-3 |
GO:0034405 | response to fluid shear stress | 5.197658e-3 |
GO:0034626 | fatty acid elongation, polyunsaturated fatty acid | 5.233604e-3 |
GO:0031394 | positive regulation of prostaglandin biosynthetic process | 5.238425e-3 |
GO:0090130 | tissue migration | 5.323314e-3 |
GO:0046168 | glycerol-3-phosphate catabolic process | 5.326636e-3 |
GO:0043103 | hypoxanthine salvage | 5.326636e-3 |
GO:0032261 | purine nucleotide salvage | 5.326636e-3 |
GO:0060997 | dendritic spine morphogenesis | 5.350688e-3 |
GO:0031581 | hemidesmosome assembly | 5.367930e-3 |
GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity | 5.382580e-3 |
GO:0006040 | amino sugar metabolic process | 5.460873e-3 |
GO:0070509 | calcium ion import | 5.584498e-3 |
GO:0003214 | cardiac left ventricle morphogenesis | 5.605436e-3 |
GO:0070293 | renal absorption | 5.619082e-3 |
GO:0030913 | paranodal junction assembly | 5.619082e-3 |